Developmental Research Program
Developmental Research Program
批准号:
10289607
负责人:
GEROLD BEPLER
金额:
$8.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-20 至 2024-08-31
关键词:
Advanced Malignant NeoplasmAfrican AmericanAreaAwardCitiesClinicalCollaborationsCommunicationCommunitiesComprehensive Cancer CenterDevelopmentDiseaseEarly DiagnosisFacultyFosteringFundingFutureGoalsGrantHealthHuman ResourcesIncidenceInfrastructureInstitutesInterventionLaboratoriesMalignant NeoplasmsMentorsMethodologyMethodsMissionMonitorMorbidity - disease ratePatientsPilot ProjectsPopulation SciencesPreventionProcessProgram Research Project GrantsProgram ReviewsRaceResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesReview CommitteeScienceStage at DiagnosisStructureTranslatingTranslational ResearchUnderrepresented MinorityUnited StatesUniversitiesbasecancer health disparitydisparity reductionhealth disparityhuman subjectinnovationmeetingsmortalitynovelprogramsrecruitsoundtranslational impacttreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The primary goal of the Developmental Research Program (DRP) of this P20 application is to advance the cancer
health disparities research mission at the Karmanos Cancer Institute (KCI) by developing innovative research
projects that are scientifically sound and translatable. The DRP provides a unique opportunity for soliciting new
research ideas and encourages development of cancer health disparities projects with high translational
potential. These projects provide investigators with the resources to conduct high-impact translational research
consistent with our P20 SPORE's objectives. The goals will be achieved through the following specific aims: 1)
Solicitation of DRP proposals through a highly structured process by leveraging the existing administrative
structure of the KCI; 2) Review applications for new and renewal projects by a DRP Review Committee, which
will recommend up to two new applications and two renewal applications for funding to the Executive Committee
(except for the first year, where two new projects will be supported); 3) Monitor and evaluate funded projects for
progress and translational potential, and assess their potential to become full P50 “SPORE-ready” translational
projects; and 4) Integrate DRP investigators into the SPORE community by requiring participation in monthly
meetings and group communications, and by providing opportunities for expanded collaborations. We will utilize
KCI's existing infrastructure for the DRP to meet the translational objectives of the P20 SPORE and leverage
already established mechanisms to solicit applications. These mechanisms also serve to foster excellent
science in cancer health disparities, recruit new faculty to areas of focus, mentor junior faculty, and encourage
research collaborations. PIs of new and renewal DRP projects will be required to submit written summaries of
research accomplishments to the DRP Committee after 10 months and present these at one of the monthly
meetings of the Executive Committee comprised of the co-leaders of the SPORE projects and core directors.
This meeting will be used to determine whether the DRP projects are sufficiently meritorious for consideration
as full translational projects by the Internal Advisory Board, followed by the EAB and the P20 Cancer Action
Council, as part of a future Detroit Cancer Health Disparities P50 SPORE application. This program will
encourage participation from a broad range of investigators at KCI and Wayne State University by providing
support for pilot projects with the potential to develop into impactful translational projects. It also encourages
and facilitates the development of new research directions, methodologies, and collaborations. Importantly, KCI
has committed to provide the required funds annually for the DRP to fund up to two new projects every year at
a maximum of $50,000 per project per year (with the potential of renewal for up to two projects per year in years
2 and 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ETCTN Early Drug Development Opportunity Leadership program administrative supplement to Cancer Center Support Grant
-
批准号:10363981
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2021
-
负责人:GEROLD BEPLER
-
依托单位:
Reducing Cancer Health Disparities in Detroit
-
批准号:10289601
-
项目类别:
-
资助金额:$99.34万
-
财政年份:2021
-
负责人:GEROLD BEPLER
-
依托单位:
Developmental Research Program
-
批准号:10684289
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2021
-
负责人:GEROLD BEPLER
-
依托单位:
Developmental Research Program
-
批准号:10491131
-
项目类别:
-
资助金额:$8.27万
-
财政年份:2021
-
负责人:GEROLD BEPLER
-
依托单位:
Targeting USP10 to regulate the DNA damage response in NSCLC
-
批准号:10311543
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2020
-
负责人:GEROLD BEPLER
-
依托单位:
Targeting USP10 to regulate the DNA damage response in NSCLC
-
批准号:10112548
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2020
-
负责人:GEROLD BEPLER
-
依托单位:
Detroit Research on Cancer Survivors (Detroit ROCS)
-
批准号:10082435
-
项目类别:
-
资助金额:$165.44万
-
财政年份:2017
-
负责人:GEROLD BEPLER
-
依托单位:
Senior Leadership
-
批准号:8709336
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2013
-
负责人:GEROLD BEPLER
-
依托单位:
Protocol Specific Research Support
-
批准号:8723966
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:GEROLD BEPLER
-
依托单位:
Protocol Specific Research Support
-
批准号:8350790
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2011
-
负责人:GEROLD BEPLER
-
依托单位:
Senior Leadership
-
批准号:8350741
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2011
-
负责人:GEROLD BEPLER
-
依托单位:
Planning and Evaluation
-
批准号:8350756
-
项目类别:
-
资助金额:$3.87万
-
财政年份:2011
-
负责人:GEROLD BEPLER
-
依托单位:
Cancer Center Administration
-
批准号:8350758
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2011
-
负责人:GEROLD BEPLER
-
依托单位:
Developmental Funds
-
批准号:8350757
-
项目类别:
-
资助金额:$46.77万
-
财政年份:2011
-
负责人:GEROLD BEPLER
-
依托单位:
Program Leaders
-
批准号:8350754
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2011
-
负责人:GEROLD BEPLER
-
依托单位:
Staff Investigators
-
批准号:8350755
-
项目类别:
-
资助金额:$4.89万
-
财政年份:2011
-
负责人:GEROLD BEPLER
-
依托单位:
P4 - Lung Cancer Chemoprevention with Enzastaurin
-
批准号:8118131
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2010
-
负责人:GEROLD BEPLER
-
依托单位:
SPORE in Lung Cancer
-
批准号:7432315
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2008
-
负责人:GEROLD BEPLER
-
依托单位:
RRM1 in the Management of Lung Cancer
-
批准号:7612018
-
项目类别:
-
资助金额:$57.2万
-
财政年份:2008
-
负责人:GEROLD BEPLER
-
依托单位:
Lung Cancer Chemoprevention with Enzastaurin
-
批准号:7449122
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2008
-
负责人:GEROLD BEPLER
-
依托单位:
海外基金